Noorzaileen Eileena Zaidi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Noorzaileen Eileena Zaidi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Nik Mohd Afizan Nik Abd Rahman
Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia
2 shared publications - Nur Aima Hafiza Shazali
Institute of Tropical Forestry and Forest Products, Universiti Putra Malaysia, Serdang 43400, Malaysia
2 shared publications - Adli Ali
Department of Pediatric, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia
1 shared publication - Elena Aisha Azizan
Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur 56000, Malaysia
1 shared publication - Ferial Ghaemi
Institute of Tropical Forestry and Forest Products (INTROP), Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia
1 shared publication - Hidayah Ariffin
Department of Bioprocess Technology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, 43400, Malaysia
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2321
The Aldosterone–Immune Axis in Primary Aldosteronism: Linking Adrenal Pathogenesis to Systemic Inflammation and Target-Organ Damage
Primary aldosteronism (PA) is the most common endocrine cause of secondary hypertension and is increasingly recognised as a systemic disorder extending beyond haemodynamic dysregulation. Accumulating evidence suggests that chronic autonomous aldosterone excess promotes maladaptive immune activation, establishing an aldosterone–immune axis that may contribute to cardiovascular, renal, and metabolic injury independently of blood pressure elevation. In some patients, glucocorticoid co-secretion may further amplify tissue-specific mineralocorticoid receptor (MR) signalling. Human and experimental studies indicate that aldosterone modulates both innate and adaptive immunity. Patients with PA demonstrate altered monocyte transcriptional profiles, enhanced vascular inflammatory activity, and increased pro-inflammatory cytokine signalling in monocyte-derived macrophages compared with blood-pressure-matched essential hypertension controls. Experimental models further show that sustained aldosterone exposure promotes macrophage M1 polarisation, dendritic cell activation, Th17 expansion, and regulatory T-cell suppression. These inflammatory changes are accompanied by oxidative stress, endothelial dysfunction, fibroblast activation, and extracellular matrix remodelling across cardiovascular and renal tissues. Emerging evidence is also consistent with a role for trained innate immunity, whereby prolonged aldosterone exposure may induce persistent epigenetic and metabolic reprogramming of monocytes and macrophages. Whether such reprogramming persists after biochemical correction by adrenalectomy or MR antagonism in human PA has not yet been directly demonstrated and remains an important open question. If confirmed, these mechanisms may help explain the partial irreversibility of target-organ damage despite successful treatment. This review synthesises current evidence linking adrenal somatic pathogenesis to systemic immune dysregulation and target-organ injury in PA. We propose that PA should be viewed not solely as a hypertensive disorder, but as a chronic fibro-inflammatory endocrine disease with important implications for early diagnosis, risk stratification, and targeted therapy. Future prospective human studies are needed to confirm the mechanistic hierarchy proposed and to identify the immunological targets most amenable to therapeutic intervention.
- 13 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2321
Open AccessThe Aldosterone–Immune Axis in Primary Aldosteronism: Linking Adrenal Pathogenesis to Systemic Inflammation and Target-Organ Damage
Primary aldosteronism (PA) is the most common endocrine cause of secondary hypertension and is increasingly recognised as a systemic disorder extending beyond haemodynamic dysregulation. Accumulating evidence suggests that chronic autonomous aldosterone excess promotes maladaptive immune activation, establishing an aldosterone–immune axis that may contribute to cardiovascular, renal, and metabolic injury independently of blood pressure elevation. In some patients, glucocorticoid co-secretion may further amplify tissue-specific mineralocorticoid receptor (MR) signalling. Human and experimental studies indicate that aldosterone modulates both innate and adaptive immunity. Patients with PA demonstrate altered monocyte transcriptional profiles, enhanced vascular inflammatory activity, and increased pro-inflammatory cytokine signalling in monocyte-derived macrophages compared with blood-pressure-matched essential hypertension controls. Experimental models further show that sustained aldosterone exposure promotes macrophage M1 polarisation, dendritic cell activation, Th17 expansion, and regulatory T-cell suppression. These inflammatory changes are accompanied by oxidative stress, endothelial dysfunction, fibroblast activation, and extracellular matrix remodelling across cardiovascular and renal tissues. Emerging evidence is also consistent with a role for trained innate immunity, whereby prolonged aldosterone exposure may induce persistent epigenetic and metabolic reprogramming of monocytes and macrophages. Whether such reprogramming persists after biochemical correction by adrenalectomy or MR antagonism in human PA has not yet been directly demonstrated and remains an important open question. If confirmed, these mechanisms may help explain the partial irreversibility of target-organ damage despite successful treatment. This review synthesises current evidence linking adrenal somatic pathogenesis to systemic immune dysregulation and target-organ injury in PA. We propose that PA should be viewed not solely as a hypertensive disorder, but as a chronic fibro-inflammatory endocrine disease with important implications for early diagnosis, risk stratification, and targeted therapy. Future prospective human studies are needed to confirm the mechanistic hierarchy proposed and to identify the immunological targets most amenable to therapeutic intervention.
- Open Access
CD36-Fatty Acid-Mediated Metastasis via the Bidirectional Interactions of Cancer Cells and Macrophages
Tumour heterogeneity refers to the complexity of cell subpopulations coexisting within the tumour microenvironment (TME), such as proliferating tumour cells, tumour stromal cells and infiltrating immune cells. The bidirectional interactions between cancer and the surrounding microenvironment mark the tumour survival and promotion functions, which allow the cancer cells to become invasive and initiate the metastatic cascade. Importantly, these interactions have been closely associated with metabolic reprogramming, which can modulate the differentiation and functions of immune cells and thus initiate the antitumour response. The purpose of this report is to review the CD36 receptor, a prominent cell receptor in metabolic activity specifically in fatty acid (FA) uptake, for the metabolic symbiosis of cancer–macrophage. In this review, we provide an update on metabolic communication between tumour cells and macrophages, as well as how the immunometabolism indirectly orchestrates the tumour metastasis.
Open AccessCD36-Fatty Acid-Mediated Metastasis via the Bidirectional Interactions of Cancer Cells and Macrophages
Tumour heterogeneity refers to the complexity of cell subpopulations coexisting within the tumour microenvironment (TME), such as proliferating tumour cells, tumour stromal cells and infiltrating immune cells. The bidirectional interactions between cancer and the surrounding microenvironment mark the tumour survival and promotion functions, which allow the cancer cells to become invasive and initiate the metastatic cascade. Importantly, these interactions have been closely associated with metabolic reprogramming, which can modulate the differentiation and functions of immune cells and thus initiate the antitumour response. The purpose of this report is to review the CD36 receptor, a prominent cell receptor in metabolic activity specifically in fatty acid (FA) uptake, for the metabolic symbiosis of cancer–macrophage. In this review, we provide an update on metabolic communication between tumour cells and macrophages, as well as how the immunometabolism indirectly orchestrates the tumour metastasis.
- Open Access
Characterization and Cellular Internalization of Spherical Cellulose Nanocrystals (CNC) into Normal and Cancerous Fibroblasts
The aim was to isolate cellulose nanocrystals (CNC) from commercialized oil palm empty fruit bunch cellulose nanofibre (CNF) through sulphuric acid hydrolysis and explore its safeness as a potential nanocarrier. Successful extraction of CNC was confirmed through a field emission scanning electron microscope (FESEM) and attenuated total reflection Fourier transmission infrared (ATR-FTIR) spectrometry analysis. For subsequent cellular uptake study, the spherical CNC was covalently tagged with fluorescein isothiocyanate (FITC), resulting in negative charged FITC-CNC nanospheres with a dispersity (Ð) of 0.371. MTT assay revealed low degree cytotoxicity for both CNC and FITC-CNC against C6 rat glioma and NIH3T3 normal fibroblasts up to 50 µg/mL. FITC conjugation had no contribution to the particle’s toxicity. Through confocal laser scanning microscope (CLSM), synthesized FITC-CNC manifested negligible cellular accumulation, indicating a poor non-selective adsorptive endocytosis into studied cells. Overall, an untargeted CNC-based nanosphere with less cytotoxicity that posed poor selectivity against normal and cancerous cells was successfully synthesized. It can be considered safe and suitable to be developed into targeted nanocarrier.
Open AccessCharacterization and Cellular Internalization of Spherical Cellulose Nanocrystals (CNC) into Normal and Cancerous Fibroblasts
The aim was to isolate cellulose nanocrystals (CNC) from commercialized oil palm empty fruit bunch cellulose nanofibre (CNF) through sulphuric acid hydrolysis and explore its safeness as a potential nanocarrier. Successful extraction of CNC was confirmed through a field emission scanning electron microscope (FESEM) and attenuated total reflection Fourier transmission infrared (ATR-FTIR) spectrometry analysis. For subsequent cellular uptake study, the spherical CNC was covalently tagged with fluorescein isothiocyanate (FITC), resulting in negative charged FITC-CNC nanospheres with a dispersity (Ð) of 0.371. MTT assay revealed low degree cytotoxicity for both CNC and FITC-CNC against C6 rat glioma and NIH3T3 normal fibroblasts up to 50 µg/mL. FITC conjugation had no contribution to the particle’s toxicity. Through confocal laser scanning microscope (CLSM), synthesized FITC-CNC manifested negligible cellular accumulation, indicating a poor non-selective adsorptive endocytosis into studied cells. Overall, an untargeted CNC-based nanosphere with less cytotoxicity that posed poor selectivity against normal and cancerous cells was successfully synthesized. It can be considered safe and suitable to be developed into targeted nanocarrier.